this post was submitted on 05 Jun 2025
475 points (98.2% liked)

Technology

70942 readers
3371 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related news or articles.
  3. Be excellent to each other!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, this includes using AI responses and summaries. To ask if your bot can be added please contact a mod.
  9. Check for duplicates before posting, duplicates may be removed
  10. Accounts 7 days and younger will have their posts automatically removed.

Approved Bots


founded 2 years ago
MODERATORS
 

Over the last several decades, the Food and Drug Administration has allowed pharma companies to sell hundreds of drugs to patients without adequate evidence that they work and, in many cases, with clear signs that they pose a risk of serious harm.

you are viewing a single comment's thread
view the rest of the comments
[–] Neuromancer49@midwest.social 14 points 1 day ago (1 children)

The consent process for clinical trials has a ton of guidance (ICH GCP), but the onus is on the clinical monitors and hospitals to make sure it's done correctly. Many trials now generate supporting documentation in which hospital staff are required to describe the circumstances in which consent was acquired. If the documents are generated, then it's auditable.

Things get a bit hairy when you look at trials in Alzheimer's and other cognitive disorders, because the patient may not be coherent enough to withdraw from the trial. In those cases, a legal guardian is responsible for the decision.

[–] ClockworkOtter@lemmy.world 6 points 1 day ago (1 children)

Yes, though if the sponsor is doing it on the cheap then they might pick facilities and monitors who don't care or don't have the capacity to pick up on all the details, or scrutinise minutiae. The monitor can only QC what's written down for example, and an investigator can be perfectly capable of having the bare minimum of a consent process and copy pasta as if it was done thoroughly.

I'm glad all my participants are of sound mind; the idea of navigating the world of incapacity and research gives me the heebie jeebies.

[–] Neuromancer49@midwest.social 5 points 1 day ago (1 children)

Good point, I'm assuming all monitors are as good as mine.

[–] ClockworkOtter@lemmy.world 2 points 1 day ago

I wish all mine were as good as the best I've had.